Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief.
Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.
Cancer Groups Propose Six Characteristics Of Next FDA Head.
NCCS Urges FDA To Finalize Regulations On Expanded Access.
NCI Advisors Approve Continuation Of Cancer Genome Atlas Network.
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Joe Fraumeni, founder of molecular epidemiology, dies at 93
“It’s hard to imagine a world without the presence of this gentle scientific giant.” - The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions” - Early-onset colorectal cancer is behaving like a new, biologically distinct disease, researchers note
One woman’s pregnancy shows how this distinction matters - Robert Mayer tells us about pancreatic cancer’s hopeless past as new data shows promise
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members









